Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurie Markman

Showing results (21-30 of 413) with videos related to

Pageof 42
Sort By:
Oncology|July 10, 2019
The Evolving Arena of Ovarian Cancer Maintenance TherapyMaurie Markman
Seminars in Oncology|February 13, 2002
Second-line treatment of ovarian cancer with single-agent gemcitabineMaurie Markman
Current Oncology Reports|December 17, 2008
Progression-free survival versus overall survival as the primary end point in anticancer drug trials: increasingly relevant impact of therapy following progressionMaurie Markman
Nature Reviews. Clinical Oncology|September 30, 2009
Chemotherapy: Topotecan or treosulfan--that is the questionMaurie Markman
Current Oncology Reports|October 3, 2003
Surgical staging of cancer: impact on prognosis and potential for bias in clinical trialsMaurie Markman
Cancer|August 28, 2003
Informing patients with cancer of "new findings" that may influence their willingness to participate in research studiesMaurie Markman
Expert Opinion on Drug Safety|October 31, 2003
Toxicities of the platinum antineoplastic agentsMaurie Markman
Cancer|October 26, 2007
The role of independent review to insure ethical quality-improvement activities in oncology: a commentary on the national debate regarding the distinction between quality-improvement initiatives and clinical researchMaurie Markman
Gynecologic Oncology|November 16, 2007
Critical thinking: an essential role in both the conduct and interpretation of gynecologic cancer clinical researchMaurie Markman
Gynecologic Oncology|January 29, 2002
Hypersensitivity reactions to carboplatinMaurie Markman
Pageof 42

Showing results (21-30 of 413) with videos related to

Sort By:
Pageof 42
Oncology|July 10, 2019
The Evolving Arena of Ovarian Cancer Maintenance TherapyMaurie Markman
Seminars in Oncology|February 13, 2002
Second-line treatment of ovarian cancer with single-agent gemcitabineMaurie Markman
Current Oncology Reports|December 17, 2008
Progression-free survival versus overall survival as the primary end point in anticancer drug trials: increasingly relevant impact of therapy following progressionMaurie Markman
Nature Reviews. Clinical Oncology|September 30, 2009
Chemotherapy: Topotecan or treosulfan--that is the questionMaurie Markman
Current Oncology Reports|October 3, 2003
Surgical staging of cancer: impact on prognosis and potential for bias in clinical trialsMaurie Markman
Cancer|August 28, 2003
Informing patients with cancer of "new findings" that may influence their willingness to participate in research studiesMaurie Markman
Expert Opinion on Drug Safety|October 31, 2003
Toxicities of the platinum antineoplastic agentsMaurie Markman
Cancer|October 26, 2007
The role of independent review to insure ethical quality-improvement activities in oncology: a commentary on the national debate regarding the distinction between quality-improvement initiatives and clinical researchMaurie Markman
Gynecologic Oncology|November 16, 2007
Critical thinking: an essential role in both the conduct and interpretation of gynecologic cancer clinical researchMaurie Markman
Gynecologic Oncology|January 29, 2002
Hypersensitivity reactions to carboplatinMaurie Markman
Pageof 42